Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Beggs

Showing results (81-90 of 407) with videos related to

Pageof 41
Sort By:
Antimicrobial Agents and Chemotherapy|November 1, 1987
Is it morphologic type or physiologic state that governs susceptibility of Candida albicans to clotrimazole kill?W H Beggs, I R LaSota, C E Hughes
Antimicrobial Agents and Chemotherapy|February 1, 1978
Synergistic action of amphotericin B and antioxidants against certain opportunistic yeast pathogensW H Beggs, F A Andrews, G A Sarosi
Life Sciences|January 12, 1981
Action of imidazole-containing antifungal drugsW H Beggs, F A Andrews, G A Sarosi
Antimicrobial Agents and Chemotherapy|April 1, 1977
Influence of antioxidants on the bioactivity of amphotericin BF A Andrews, W H Beggs, G A Sarosi
The Journal of General Virology|January 1, 1990
Cell type-specific expression of JC virus T antigen in primary and established cell lines from transgenic miceA H Beggs, J H Miner, G A Scangos
American Journal of Medical Genetics|October 1, 1992
Additional dystrophin fragment in Becker muscular dystrophy may result from proteolytic cleavage at deletion junctionsA H Beggs, E P Hoffman, L M Kunkel
Neuromuscular Disorders : NMD|May 5, 1998
51st ENMC International Workshop: Nemaline Myopathy. 13-15 June 1997, Naarden, The NetherlandsC Wallgren-Pettersson, A H Beggs, N G Laing
Research Communications in Chemical Pathology and Pharmacology|May 1, 1978
Antioxidant enhancement of amphotericin B activity against Candida albicansW H Beggs, F A Andrews, G A Sarosi
Clinical Chemistry|July 1, 1989
Molecular genetics of Duchenne and Becker muscular dystrophy: emphasis on improved diagnosisL M Kunkel, A H Beggs, E P Hoffman
Antimicrobial Agents and Chemotherapy|June 1, 1976
Inhibition of potentially pathogenic yeastlike fungi by clotrimazole in combination with 5-fluorocytosine or amphotericin BW H Beggs, G A Sarosi, N M Steele
Pageof 41

Showing results (81-90 of 407) with videos related to

Sort By:
Pageof 41
Antimicrobial Agents and Chemotherapy|November 1, 1987
Is it morphologic type or physiologic state that governs susceptibility of Candida albicans to clotrimazole kill?W H Beggs, I R LaSota, C E Hughes
Antimicrobial Agents and Chemotherapy|February 1, 1978
Synergistic action of amphotericin B and antioxidants against certain opportunistic yeast pathogensW H Beggs, F A Andrews, G A Sarosi
Life Sciences|January 12, 1981
Action of imidazole-containing antifungal drugsW H Beggs, F A Andrews, G A Sarosi
Antimicrobial Agents and Chemotherapy|April 1, 1977
Influence of antioxidants on the bioactivity of amphotericin BF A Andrews, W H Beggs, G A Sarosi
The Journal of General Virology|January 1, 1990
Cell type-specific expression of JC virus T antigen in primary and established cell lines from transgenic miceA H Beggs, J H Miner, G A Scangos
American Journal of Medical Genetics|October 1, 1992
Additional dystrophin fragment in Becker muscular dystrophy may result from proteolytic cleavage at deletion junctionsA H Beggs, E P Hoffman, L M Kunkel
Neuromuscular Disorders : NMD|May 5, 1998
51st ENMC International Workshop: Nemaline Myopathy. 13-15 June 1997, Naarden, The NetherlandsC Wallgren-Pettersson, A H Beggs, N G Laing
Research Communications in Chemical Pathology and Pharmacology|May 1, 1978
Antioxidant enhancement of amphotericin B activity against Candida albicansW H Beggs, F A Andrews, G A Sarosi
Clinical Chemistry|July 1, 1989
Molecular genetics of Duchenne and Becker muscular dystrophy: emphasis on improved diagnosisL M Kunkel, A H Beggs, E P Hoffman
Antimicrobial Agents and Chemotherapy|June 1, 1976
Inhibition of potentially pathogenic yeastlike fungi by clotrimazole in combination with 5-fluorocytosine or amphotericin BW H Beggs, G A Sarosi, N M Steele
Pageof 41